donor lymphocyte infusion for relapsed myelofibrosis in the post-allosct setting
Published 5 months ago • 184 plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:02:08
allogeneic stem cell transplantation for myelofibrosis
-
15:13
my bone marrow transplant journey | day -11 to day 150 | vlog | leukaemia |aml | cancer |
-
2:21
mezigdomide: a novel celmod showing promise in the treatment of r/r myeloma
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
14:25
donor lymphocyte infusion by dr xiao jun huang
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
1:23
the challenge of relapse in transplant-eligible & transplant-ineligible patients with bdpcn
-
2:02
panobinostat and donor lymphocyte infusions in patients with high-risk aml and mds
-
1:31
the role of haploidentical transplantation in myelofibrosis
-
4:48
an insight into the management of cytopenias in mf
-
2:33
dli following haplohct ptcy relapse
-
2:57
selecting patients with myelofibrosis for allosct: molecular, patient & transplant-related factors
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:51
factors driving the transformation of chip to mds
-
2:36
leukemia immune evasion in relapse after haploidentical hematopoietic cell transplantation
-
1:36
the role of molecular markers in patient selection for transplantation in myelofibrosis
-
1:28
phase i study of pevonedistat and ibrutinib in r/r b-nhl
-
1:55
donor type and source of choice
-
1:11
personalized risk assessment for transplantation in primary immunodeficiency disorders
-
1:34
the mutational profile in patients with cll treated with acalabrutinib or ibrutinib
-
1:30
the role of dli & molecular monitoring in patients with myelofibrosis who relapse after sct